Back to search results

MIRROR Study: Interventions for Female Veterans with Trauma and Brain Injury

The MIRROR study is testing two different approaches to help female Veterans who have experienced military sexual trauma (MST), intimate partner violence (IPV), and a brain injury. These approaches are called webSTAIR and ExpoTx. webSTAIR uses online modules and therapist support to help with managing emotions. ExpoTx focuses on improving daily social and mental functioning without reliving past traumas. Some participants will also receive PsychoEd, which teaches about mental health symptoms related to trauma. The study aims to see which approach is better at improving emotion regulation and reducing symptoms of post-traumatic stress disorder (PTSD). To join, you must be a female Veteran, 18 or older, speak English, have experienced IPV and/or MST, have a history of brain injury, and have certain levels of PTSD symptoms. The study plans to enroll 136 participants.

Study design
This study is comparing two different interventions in 136 female Veterans. Participants will be randomly assigned to receive either webSTAIR plus ExpoTx, or PsychoEd plus ExpoTx.
What's involved
Participants will complete ten web-based modules (about two per week) and have five video-telehealth meetings with a therapist. The study measures will be taken at week 0, week 2.5, week 5, week 7.5, week 10, and month 3.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 months after starting the interventions.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06988787

Multifaceted Intervention to Restore Resilience and Overcome Risk

Recruiting
NAAges 18+InterventionalTreatment
Icahn School of Medicine at Mount Sinai
~136 participants
Updated 2025-12-10 on ClinicalTrials.gov
What's tested:webSTAIRExpoTxPsychoEd

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Difficulties in Emotion Regulation Scale (DERS)
Measured over At week 0, week 2.5, week 5, week 7.5, week 10, and month 3

Conditions

Military Sexual Trauma
Intimate Partner Violence
Brain Injury
Post Traumatic Stress Disorder

Explore related trials

Brain InjuryIntimate Partner ViolenceMilitary Sexual TraumaPost-Traumatic Stress Disorder

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Maria Kajankova, PhD · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai

Who to contact

Maria Kajankova, PhD
[email protected]
212-241-3379
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Able to consent as determined by UBACC, are English-speaking FVets who are 18+ years old
Screen positive for exposure to IPV and/or MST using the VA Intimate Partner Violence Assistance Program (VA IPVAP) and MST Screening Protocol,
Have a history of at least one BI assessed using the BISQ+IPV,
Sub-threshold PTSD (operationalized as a total score of \>33 on the PTSD Checklist Diagnostic and Statistical Manual of Mental Disorders-5 (PCL-5),
Report deficits in Emotion Regulation (operationalized as a score of 0.5 SD above published means on the DERS).

Exclusion

FVets at high risk for suicide (respond yes to items 3, 4, 5, or 8 on the Columbia Suicide Severity Rating Scale \[C-SSRS\]),
Observable active psychosis (e.g., auditory hallucinations, grandiose delusions),
Those determined to have problematic substance use (score \> 27 on the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) will be referred to substance use dependence programs for concurrent treatment. The PI and Co-Is will collaborate with the substance use dependence program to determine continued participation.

What this trial measures

  • Difficulties in Emotion Regulation Scale (DERS)At week 0, week 2.5, week 5, week 7.5, week 10, and month 3

    The DERS is a 36-item self-report measure that assesses emotion dysregulation in six domains: nonacceptance of emotional responses (subscale score 6-30), difficulties engaging in goal directed behavior (subscale score 5-25), impulse control difficulties (subscale score 6-30), lack of emotional awareness (subscale score 6-30), limited access to emotion regulation strategies (subscale score 8-40), and lack of emotional clarity (subscale score 5-25). Items are rated on a scale of 1 ("almost never \[0-10%\]") to 5 ("almost always \[91-100%\]"). Total Score range from 36-180, with higher scores indicating more difficulty in emotion regulation.